176 related articles for article (PubMed ID: 21725499)
1. Neuroprotective effect of exogenous melatonin on dopaminergic neurons of the substantia nigra in ovariectomized rats.
Mehraein F; Talebi R; Jameie B; Joghataie MT; Madjd Z
Iran Biomed J; 2011; 15(1-2):44-50. PubMed ID: 21725499
[TBL] [Abstract][Full Text] [Related]
2. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant role of oleuropein on midbrain and dopaminergic neurons of substantia nigra in aged rats.
Sarbishegi M; Mehraein F; Soleimani M
Iran Biomed J; 2014; 18(1):16-22. PubMed ID: 24375158
[TBL] [Abstract][Full Text] [Related]
4. Estrogen modulation of calretinin and BDNF expression in midbrain dopaminergic neurons of ovariectomised mice.
Yi H; Bao X; Tang X; Fan X; Xu H
J Chem Neuroanat; 2016 Nov; 77():60-67. PubMed ID: 27211874
[TBL] [Abstract][Full Text] [Related]
5. Influence of aging on the dopaminergic neurons in the substantia nigra pars compacta of rats.
Gao J; Miao H; Xiao CH; Sun Y; Du X; Yuan HH; Yu HL; Gao DS
Curr Aging Sci; 2011 Feb; 4(1):19-24. PubMed ID: 21204780
[TBL] [Abstract][Full Text] [Related]
6. Estrogen effects on tyrosine hydroxylase-immunoreactive cells in the ventral mesencephalon of the female rat: further evidence for the two cell hypothesis of dopamine function.
Zsarnovszky A; Scalise TJ; Horvath TL; Naftolin F
Brain Res; 2000 Jun; 868(2):363-6. PubMed ID: 10854590
[TBL] [Abstract][Full Text] [Related]
7. Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine.
Ferraz AC; Xavier LL; Hernandes S; Sulzbach M; Viola GG; Anselmo-Franci JA; Achaval M; Da Cunha C
Brain Res; 2003 Oct; 986(1-2):200-5. PubMed ID: 12965246
[TBL] [Abstract][Full Text] [Related]
8. Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E.
Ueda S; Sakakibara S; Nakadate K; Noda T; Shinoda M; Joyce JN
Neurosci Lett; 2005 Jun; 380(3):252-6. PubMed ID: 15862896
[TBL] [Abstract][Full Text] [Related]
9. Does melatonin help save dopaminergic cells in MPTP-treated mice?
Ma J; Shaw VE; Mitrofanis J
Parkinsonism Relat Disord; 2009 May; 15(4):307-14. PubMed ID: 18793863
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.
Gui ZH; Liu J; Wang Y; Ali U; Wang T; Chen L
Chin J Physiol; 2011 Apr; 54(2):96-104. PubMed ID: 21789890
[TBL] [Abstract][Full Text] [Related]
11. [Sexual dimorphisms of dopaminergic neurons in rat substantia nigra].
Ma YY; Kong SZ; Yang LJ; Meng JL; Lv LC; He M
Sheng Li Xue Bao; 2007 Dec; 59(6):753-8. PubMed ID: 18157467
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
Liu LX; Chen WF; Xie JX; Wong MS
Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
[TBL] [Abstract][Full Text] [Related]
13. Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic system.
Kim YS; Joo WS; Jin BK; Cho YH; Baik HH; Park CW
Neuroreport; 1998 Jul; 9(10):2387-90. PubMed ID: 9694233
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of pramipexole in young and aged MPTP-treated mice.
Anderson DW; Neavin T; Smith JA; Schneider JS
Brain Res; 2001 Jun; 905(1-2):44-53. PubMed ID: 11423078
[TBL] [Abstract][Full Text] [Related]
15. The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.
Panneton WM; Kumar VB; Gan Q; Burke WJ; Galvin JE
PLoS One; 2010 Dec; 5(12):e15251. PubMed ID: 21179455
[TBL] [Abstract][Full Text] [Related]
16. N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats.
Guan J; Krishnamurthi R; Waldvogel HJ; Faull RL; Clark R; Gluckman P
Brain Res; 2000 Mar; 859(2):286-92. PubMed ID: 10719076
[TBL] [Abstract][Full Text] [Related]
17. Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats.
Capitelli C; Sereniki A; Lima MM; Reksidler AB; Tufik S; Vital MA
Eur J Pharmacol; 2008 Oct; 594(1-3):101-8. PubMed ID: 18674531
[TBL] [Abstract][Full Text] [Related]
18. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
[TBL] [Abstract][Full Text] [Related]
19. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
Porritt MJ; Batchelor PE; Howells DW
Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
